Condition: Brain Metastases, Adult · Brain Tumor - Metastatic · Brain Metastases From Non-small Cell Lung Cancer (NSCLC) · Sponsor: Ayal A. Aizer, MD
The goal of this study is to evaluate the feasibility and effectiveness of same-day radiation planning and treatment. The study will shorten the time interval between radiation planning (radiation mapping) and radiation treatment. The intent of this shorter time interval is to increase the likelihood that the brain metastases being treated remain fully within the high-dose radiation fields. Participants will be randomized to receive brain-directed stereotactic radiation with a 1mm margin or 0mm margin, have their simulation/radiation planning imaging on the same day that brain-directed stereotactic radiation is delivered, and have repeat simulation/radiation planning scans during the course of treatment if more than 2-3 days have elapsed since the most recent scans.
This description comes directly from the study's public registry record.
Ayal A Aizer, MD, MHS · (617) 732-7560 · aaaizer@partners.org
Ivy B Ricca, BA · (617) 582-8927 · iricca@mgb.org
Always discuss trial participation with your own doctor first.
| Brigham and Women's Hospital / Dana-Farber Cancer Institute | Boston, Massachusetts, United States | Recruiting |
Get one email when the public record changes — results posted, or the study's status changes. Nothing else, ever.
We email about this public record only. Unsubscribe anytime with one click. Never medical advice.
This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.
Source record: clinicaltrials.gov/study/NCT07132190